RD Busam, AG Thorsell, A Flores… - Journal of Biological …, 2011 - ASBMB ... DAL-1 (differentially expressed in adenocarcinoma of the lung protein), another tumor suppressor, binds through its FERM domain to the TSLC1 C-terminal, 4.1 glycophorin C-like, cytoplasmic domain. However, the molecular basis for this interaction is unknown. ... Related articles - All 3 versions
T Sugiyama… - Rare and Uncommon Gynecological Cancers, 2011 - Springer ... Recent clinical and molecular studies support the hypothesis that CCC and mucinous cysta- denocarcinoma (MAC) are rare and refractory cancers that are biologically distinct from other EOCs. 8.1 Incidence and Clinical Behavior ... Cited by 4 - Related articles - All 2 versions
T Wang, XB Yan, JJ Zhao, J Ye, ZF Jiang, DR Wu… - Lung Cancer, 2011 - Elsevier ... the world. Signal transducers and activators of transcription 3 (STAT3) is a major oncogenic transcription factor involved in the development and progression of a number of human tumors including lung denocarcinoma. Gene ... Related articles - All 4 versions
XJ Ding, MX Liu, L Ao, YR Liang… - Virchows Archiv, 2011 - Springer ... 25 M 58 ACA II Moderately Y Table 1 Clinical and pathologic data of 25 NSCLC patients F female, M male, ACA deno- carcinoma, SCC squamous cell carcinoma, well well differenti- ated, moderately moderately differentiated, poorly poorly differentiated, N no, Y yes ... Related articles - All 4 versions
JD Roybal, Y Zang, YH Ahn, Y Yang… - Molecular Cancer …, 2011 - AACR ... Figure 1. Flt1 is a miR-200 target gene. A, Kaplan–Meier analysis of 2 cohorts of lung denocarcinoma patients on the basis of VEGFR1 expression (top quartile vs. lower 3 quartiles) in resected primary tumor specimens. The ... Cited by 2 - Related articles - All 3 versions